Back to Results
First PageMeta Content
Pharmaceuticals policy / GlaxoSmithKline / Thioethers / Drugs / Ranitidine / H2 antagonist / Over-the-counter drug / Prescription medication / Formulary / Pharmacology / Chemistry / Medicine


New Brunswick Drug Plans Formulary July 2014 Administered by Medavie Blue Cross on Behalf of the Government of New Brunswick
Add to Reading List

Document Date: 2014-08-06 14:41:45


Open Document

File Size: 3,10 MB

Share Result on Facebook

Company

Tab Co. / Zantac Apo-Ranitidine Co / A02BA02 Tab Co. / A02BA01 Tab Co. / Teva / APX ABDEFGVW Tab Co. / Social Development / AAP ADEFGVW Tab Co. / /

Currency

USD / TWD / /

/

IndustryTerm

food products / treatment of erectile/sexual dysfunction / loss products / Certain drug products / prevention of travel acquired diseases / /

MedicalCondition

diabetes / erectile/sexual dysfunction / latent tuberculosis / growth hormone deficiency / multiple sclerosis / infection / cystic fibrosis / /

MedicalTreatment

organ transplant / first aid / /

Organization

Department of Social Development Health Services Act / A - 1 / Department of Social Development / Department of Health Prescription Drug Payment Act / /

Person

Catastrophic Drug / Prescription / /

Position

COB / Minister / Pharmacist / /

Product

Zantac / Oracort / RANITIDINE / TRIAMCINOLONE / Cimetidine / Omeprazole / MISOPROSTOL / /

ProvinceOrState

New Brunswick / /

Technology

DUS / /

SocialTag